Glooko In the News

Glooko integrates Abbott’s FreeStyle Libre onto platform
Users of Abbott’s CGM device can now view data and gain additional insights through Glooko’s diabetes management platform.
Read MoreExpectations For The Connected Care Business In The Years Ahead
As we venture further into 2023, Glooko CEO Russ Johannesson shares his perspective on the connected care trends in digital therapeutics, remote patient...
Diabetes company Glooko partners with insulin dosing app Hedia
Through a new partnership, the Hedia app, which provides bolus insulin dosing recommendations, will integrate with Glooko’s connected care platform,...
Glooko adds insulin dosing recommendations to diabetes management app with Hedia collab
In addition to gathering data from glucose monitors, insulin pumps, fitness trackers and other devices, Glooko’s diabetes management platform will offer...
The connected care horizon in 2023
2023 is expected to be a year of advancements in connected care supporting patients with chronic conditions and their care teams. Glooko CEO Russ Johannesson...
Smart Insulin Pens: How They Work, And Your Experiences of Using Them
Smart insulin pens are a recent advancement making an impact on people living with diabetes. These connected pens can be used by anyone with the chronic...
Sanofi boosts ‘connected insulin’ push with Glooko deal
Sanofi formed a partnership with Glooko to support its vision of insulin-based therapies connected with glucose monitoring devices that simplify blood...